Lv2
178 积分 2025-03-13 加入
124P Incidence of activating frameshift and nonsense mutations in clinically actionable oncogenes
17小时前
求助中
Association of Measurable Residual Disease With Survival Outcomes in Patients With Acute Myeloid Leukemia
4个月前
已完结
Identificaton of a translocation with quinacrine fluorescence in a patient with acute leukemia
4个月前
已关闭
Exploring the landscape of somatic ASXL2 mutations in myeloid neoplasms: Frequency and clinical implications
4个月前
已完结
Breast cancer statistics, 2019
4个月前
已完结
Inavolisib-Based Therapy in PIK3CA -Mutated Advanced Breast Cancer
4个月前
已完结
Bemarituzumab in patients with FGFR2b-selected gastric or gastro-oesophageal junction adenocarcinoma (FIGHT): a randomised, double-blind, placebo-controlled, phase 2 study
5个月前
已完结
Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 study
5个月前
已完结
Eosinophilia in acute myeloid leukemia: Overlooked and underexamined
5个月前
已完结
Morphological subtyping of acute myeloid leukemia with maturation (AML-M2): homogeneous pink-colored cytoplasm of mature neutrophils is most characteristic of AML-M2 with t(8;21)
5个月前
已完结
皖公网安备34019202002308
